MLCi2 shapes treatment beams, enabling doctors to provide even more accurate delivery to the mark, while limiting radiation exposure to surrounding structures. The Elekta team commissioned both technology in one day. ‘The rate with which we are able to integrate MLCi2 in Elekta Small demonstrates not merely the skill of our installation teams, but also the inherent modularity of MLCi2, such as the real way the head itself is fitted and the installation of computer cabinets,’ says Russ Cox, Senior Item Supervisor. ‘iViewC was designed as a module to make it easy to install and commissioning is simple because we’re coping with an individual energy for the procedure system.In conjunction with a prior focus step the brand new method is ideal for purification of low titer supernatants. ‘Our method displays great potential as a fresh system technology for the pharmaceutical sector’, says Prof. Alois Jungbauer, who’s in negotiations with many international businesses about building pilot plant life.. Bionomics files essential U.S. Patents associated with cancer drug focus on BNO69 Bionomics Small announced today that it all offers filed further patent applications in essential markets associated with its proprietary cancer medication focus on BNO69.